Rebreath175 mg/3 ml
OTC- Generic:
- Revefenacin
- Company:
- The ACME Laboratories Ltd.
- Dosage form:
- Solution For Inhalation
- Pack size:
- 3ml Ampoule
Save to my medicines
Alert me on price drop
৳ 80/unit
Pack: ৳ 80
At a glance
Revefenacin is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is inhaled once daily via nebulizer and provides bronchodilation.
Indications
- Maintenance treatment of chronic obstructive pulmonary disease (COPD)
Dosage
Adult Dose (Inhalation):
- COPD maintenance: 175 mcg (one unit-dose vial) once daily via nebulizer using a mouthpiece
- Administer at the same time each day
- Hepatic impairment: Safety not evaluated; not recommended in any degree of hepatic impairment
- Renal impairment: No dosage adjustment required
Side effects
Side Effects (1-10%):
- Cough (4%)
- Nasopharyngitis (4%)
- Headache (4%)
- Upper respiratory tract infection (3%)
- Back pain (2%)
- Hypertension (1-2%)
- Dizziness (1-2%)
- Oropharyngeal pain (1-2%)
- Bronchitis (1-2%)
Precautions & warnings
- Do not initiate during acutely deteriorating or life-threatening COPD episodes
- Intended for maintenance treatment; not for relief of acute symptoms
- Paradoxical bronchospasm may occur (life-threatening); treat with short-acting bronchodilator and discontinue
- Caution in narrow-angle glaucoma (eye pain, blurred vision, visual halos) and urinary retention (prostatic hyperplasia)
- Immediate hypersensitivity reactions: Discontinue
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.